Ursal, Kent B.

HRN: 22-41-36  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/06/2023
CEFTAZIDIME 1GM (VIAL)
01/06/2023
01/12/2023
IVT
115
Q8hrs
Neonatal Sepsis
Waiting Final Action 
01/07/2023
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
01/07/2023
01/14/2023
IV
14mg Loading Dose; 7.5mg IV
OD
Neonatal Sepsis
Waiting Final Action 
01/08/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
01/08/2023
01/14/2023
IVT
35mg
OD
Neonatal Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: